A stapled peptide project combines sequence assembly with a site-specific macrocyclization. The desired product must be distinguished from uncyclized precursor, partially reacted material, deletion sequences and staple-related isomers. A custom stapled peptide synthesis service should therefore quote route development and structural evidence, not only final HPLC purity.
Define staple chemistry and positions
State the two modified residues, stereochemistry, spacing and cyclization chemistry. Hydrocarbon staples, lactam bridges and other constraints are not interchangeable. The positions are normally selected to support the intended conformation while avoiding essential binding contacts, but this remains an experimental design decision.
Order an unstapled or appropriately substituted control when the study needs to separate sequence effects from conformational constraint.
Watch the crude conversion
Non-natural amino-acid coupling may be less efficient than standard residues, particularly in aggregating sequences. On-resin cyclization can leave starting material or create side products. Ask for crude LC-MS before and after cyclization so the supplier can show conversion rather than relying on purification to conceal a weak reaction.
Purification is often the bottleneck
The staple commonly increases hydrophobicity. The target, uncyclized precursor and deletion products may have close retention. Preparative loading, temperature and ion-pair conditions need sequence-specific adjustment. A high analytical purity result may correspond to poor isolated recovery; request both.
During concentration and lyophilization, hydrophobic stapled peptides can adsorb or aggregate. Review container recovery and the final solubility test at a useful concentration.
Identity needs orthogonal evidence
LC-MS should confirm the complete product mass and show relevant charge states. It may not prove the exact bridge position when isomeric alternatives exist. Tandem MS, mapping or route-specific protection evidence can strengthen the assignment.
Circular dichroism can compare secondary structure under a defined solvent, concentration and temperature. A helical CD signature is supportive characterization, not a universal release test or proof of biological activity.
Control catalyst and reagent residues
Some staple chemistries use metal catalysts or specialized reagents. Define a risk-based residual test and reporting limit where relevant. HPLC-UV and routine MS do not provide a general elemental-impurity result.
Scale-up requires another review
Resin mixing, cyclization concentration and preparative recovery change with scale. Use a pilot lot before committing gram quantities. Lock the staple building blocks, resin, cyclization conditions and analytical method through change control.
- Exact residue positions, stereochemistry and staple type.
- Crude conversion and final HPLC/LC-MS data.
- Uncyclized and partially stapled impurity review.
- Residual catalyst assessment where applicable.
- Solubility, content basis and packaging.
Can every helical sequence be successfully stapled? No. Synthesis feasibility, conformational response and functional behavior are separate questions. Provide the sequence, intended positions, control design, scale and assay conditions so the supplier can identify chemistry and purification risks before starting.